Introduction: Dental pulp-derived stem cells (DPSCs) have the potential to regenerate dentin and dental pulp tissue because of their differentiation capacity and angiogenic properties. However, for regenerative approaches to gain regulatory and clinical acceptance, protocols are needed to determine more feasible ways to cultivate DPSCs, namely, without the use of xenogeneic-derived components (animal sera) and exogenous growth factors. Methods: In this study, human DPSCs were isolated from third molars and expanded in standard culture conditions containing fetal bovine serum (DPSCs-FBS) or conditions containing human serum (DPSCs-HS). After cell characterization and evaluation of their angiogenic secretome, DPSCs were seeded in tooth slice/scaffolds and implanted subcutaneously into immunodeficient mice. After 30 days, tooth slices were retrieved and evaluated for dental pulp tissue regeneration. Immunohistochemistry and confocal microscopy were used to quantify blood vessel formation and evaluate predentin and dentin formation. Results: After culture, DPSCs-HS produced concentrations of angiogenic growth factors equivalent to DPSCs-FBS. Additionally, in DPSCs-HS, several angiogenic factors were produced in at least 1-fold higher concentrations than in DPSCs-FBS. In vivo, it was determined that DPSCs-HS produced a robust angiogenic response and regeneration of dentin equivalent to DPSCs-FBS. Conclusions: These findings show that DPSCs can be isolated and expanded to clinical scale numbers in media devoid of animal serum or exogenous growth factors and still maintain their pulp regenerative properties. The implications of these findings are significant for further development of clinical protocols using DPSCs in cell therapies. (J Endod 2017;43:568-574) 
A ffecting over 92% of adults, dental caries is globally the most prevalent chronic disease in both adults and children (http://www.nidcr.nih.gov/ DataStatistics/FindDataBy Topic/DentalCaries). Despite the array of restorative and endodontic modalities used to treat carious lesions, regenerating lost tooth structure and pulp tissue would be the ideal way to treat this disease. In the context of regenerative therapies, dental pulp-derived stem cells (DPSCs) provide promise for regenerating lost dental pulp and tooth tissue because of their ability to differentiate into odontoblasts and vascular cells to form pulplike tissues (1) (2) (3) (4) (5) (6) (7) (8) (9) . A variety of protocols have emerged that describe different isolation and expansion methodologies for DPSCs. Although varying degrees of efficacy have been shown in these studies, a limitation to most current protocols is that the expansion of cells requires animal serum or the use of a number of exogenous growth factors. Before use in clinical applications, preclinical studies are needed that show that DPSCs can be predictably and efficiently procured under conditions that are more practical and cost-efficient for the clinical setting. We recently showed a clinically feasible means of tooth storage, DPSC isolation, and expansion of DPSCs without the use of animal serum (10) . This study showed that saline was a suitable overnight storage media for third molars in order to isolate viable DPSCs using human serum instead of animal serum. However, the influence of these culture conditions on the capacity of DPSCs to regenerate pulp tissue was not determined in vivo.
The tooth slice model has been used to evaluate pulp regeneration using different regenerative approaches involving in vivo cell transplantation (11) . Using this model, we have shown that in vivo transplantation of stem cells from exfoliated deciduous teeth (SHEDs) yields a robust angiogenic response and formation of dentin. As such, we used this model to determine if DPSCs isolated in conditions free of animal serum and exogenous growth factors, not only maintain their angiogenic capacity but also their in vivo capacity to regenerate pulp tissue. The hypothesis of the present study was that DPSCs expanded in human serum could regenerate dental pulp tissue in this in vivo model of dental pulp regeneration.
Methods Tooth Storage and DPSC Isolation
Third molars were obtained from tooth extractions from patients ranging in age from 18-22 years and were placed in sterile saline solution according to the University of Michigan Institutional Review Board guidelines. The isolation of DPSCs was performed as previously described (2) . Briefly, the crown of the tooth was cut just above the cementoenamel junction to open up the contents of the pulp. The pulp cells in the chamber and canals were cleaned out using various instruments, avoiding nerve tissue, and placed in Iscove modified Dulbecco medium (IMDM) without serum. After isolation, the cell suspension was placed in a conical tube and centrifuged at 1600 rpm for 5 minutes at room temperature. The supernatant was aspirated, and the pellet was resuspended in a 4 mg/ml dispase II/2 mg/ml collagenase solution. The solution was placed at 37 C for 60 minutes, inverting the tube at 15-minute intervals. IMDM was added to the cells before the suspension was centrifuged at room temperature for 5 minutes at 1600 rpm. The cell pellet was resuspended in IMDM without serum. This cell suspension was placed in a T-25 tissue culture flask (Corning, Tewksbury, MA) containing 1 of the following: 15% fetal bovine serum + 100 uM ascorbic acid 2 phosphate + alpha minimum essential medium (a-MEM) (DPSCs-FBS) or 15% human serum + a-MEM (DPSCs-HS) (10) .
Cell Proliferation/Population Doubling Time
Cells counts were performed at each passage, and the population doubling time (PDT) was calculated and compared between conditions. To determine the PDT, the following calculation was used:
ð# days from P 0 to P 1 Þðlog 2Þ ðlog P 1 À log P 0 Þ where P 0 is the number of cells at the initial passage and P 1 is the number of cells at the next passage.
Cell Surface Marker Expression
Flow cytometry was performed to determine the expression levels of the cell surface markers CD90, CD73, CD105, and CD-45. DPSCs were harvested from T150 flasks (Corning), washed, and aliquoted equally into tubes. Cells were first incubated with a blocking solution containing CD16/CD32 at 4 C for 10 minutes followed by washing. Cells were then incubated with the specific antibodies conjugated with fluorochromes (Biolegends, San Diego, CA) at 4 C for 30 minutes. After washing, these cells were analyzed on a Beckman Coulter MoFlo flow cytometer (Beckman, Indianapolis, IN).
Angiogenesis Array
DPSCs were grown in either 15% FBS (DPSCs-FBS) or 15% human sera (DPSCs-HS) containing a-MEM. At passages 11 (DPSCs-FBS) and 12 (DPSCs-HS), cell layers were washed with serum-free a-MEM followed by the addition of 5 mL serum-free a-MEM before the cells were incubated at 37 C for 24 hours. After incubation, the cells and conditioned media were harvested and 5 ml of conditioned media was concentrated to 1.5 ml with Millipore Centrifugal Filters (Bedford, MA) and used for the angiogenesis array. Relative levels of 55 angiogenesis-related proteins were detected in this conditioned media using the Human Angiogenesis Antibody Array (Cat. #ARY007; R&D Systems, Minneapolis, MN). DNA concentration was measured from the harvested cells. Array membranes were exposed to x-ray film. These films were analyzed by quantifying the mean spot pixel densities using the freeware Image J software (http://rsb.info.nih.gov/ij; National Institutes of Health, Bethesda, MD). Samples were standardized using DNA concentrations.
Tooth Slice Model
The animal studies outlined conformed to the Animal Research: Reporting of In Vivo Experiments guidelines for animal research. To generate tooth slices, extracted noncarious third molars were used in accordance with the University of Michigan Institutional Review Board guidelines. After being extracted, the teeth were collected in a 0.1% sodium azide solution in phosphate-buffered saline. The periodontal soft tissue was removed with a periodontal scalpel. The molar was then fixed in a transversal sectioning apparatus at the pulp chamber level. With a diamond saw at low speed, a precision cut was made using refrigerated phosphate-buffered saline for cooling. One-millimeter-thick tooth slices were obtained, and pulp tissue was gently removed. A sodium chloride sieve (250-425 mm) was placed in the pulp chamber to be used as porogen. Medical-grade poly(L-lactide) (Resomer L 207 S; Boehringer Ingelheim, Ingelheim, Germany) with a molecular weight of 250,000 g/mol was dissolved in chloroform (5%) and dropped over the salt. After solvent volatilization, specimens were immersed in distilled water and stirred for 24 hours in order to obtain the highly porous poly(L-lactide) scaffold (11, 12) .
DPSCs were cultured in either 15% fetal bovine serum (DPSCs-FBS) or 15% human serum (DPSCs-HS) containing a-MEM. At passage 5, DPSCs were harvested and resuspended in the appropriate media at a concentration of 6.7 Â 10 7 cells/mL. Ten microliters of the cell suspension was mixed at a 1:1 ratio with Matrigel (Corning #354248) at 4
C. Approximately 20 mL of the cell-Matrigel suspension was transferred to the tooth slice. Tooth slices were incubated at 37 C for 60 minutes before being surgically implanted.
The tooth slices containing either DPSCs-FBS or DPSCs-HS were transplanted into the dorsal subcutaneous space of 6-to 7-week-old ($30 g) severe combined immunodeficient mice (n = 8) (CB.17 SCID; Charles River, Wilmington, MA). In 2 of the mice from each group, 3 intraperitoneal injections of 41.6 nmol/g body weight tetracycline hydrochloride (Sigma-Aldrich, St Louis, MO) were administered after 15, 20, and 25 days after surgery as shown (4) . After 30 days, mice were euthanized, and implants were retrieved and fixed in 10% neutral buffered formaldehyde for 24 hours at 4 C until histologic processing was performed.
Histology and Immunohistochemistry: Vessel Formation
Vessel formation was evaluated as we have previously described (13, 14) . Briefly, for total blood vessel counts, vessels were identified in hematoxylin-eosin-stained tissues at Â200 magnification by histologic structures with defined lumens and the presence of red blood cells within their boundaries. For defining vessels comprised of implanted human cells, paraffin-embedded tissue sections were deparaffinized in xylene, rehydrated, washed, and incubated in antigen retrieval solution (Dako Cytomation, Carpinteria, CA) before using a 1:100 dilution of a polyclonal rabbit anti-human factor VIII antibody (Thermo-Fisher-Lab Vision, Fremont, CA). Color development was performed with a Dako EnVision system kit (AEC, Dako Cytomation) according to the manufacturer's instructions. This staining protocol enabled the localization of the vessels formed by the implanted human DPSCs. The number of microvessels in 10 random fields per implant was counted under a light microscope (100Â).
Confocal Laser Microscopy: Dentinogenesis
A confocal microscope (Leica SP5X; Leica Microsystems GmbH, Germany) with an ultraviolet laser (405 nm) was used to Regenerative Endodontics JOE -Volume 43, Number 4, April 2017
Dental Pulp Tissue Regeneration evaluate dentinogenesis as we have previously described (4) . Briefly, after the implantation of tooth slices, 3 intraperitoneal injections of 41.6 nmol/g body weight tetracycline hydrochloride (SigmaAldrich) were administered 15, 20, and 25 days after implantation. Thirty days after surgery, animals were euthanized, and mice incisors and 2 tooth slices from each group of mice treated with tetracycline were collected in phosphate-buffered saline to examine for arising fluorescent lines indicative of dentinogenesis activity. Tooth slices were examined by confocal microscopy (FluoView 500; Olympus, Tokyo, Japan) with the following parameters: ultraviolet laser (LD405 nm, 35 mW), 405-to 488-nm excitation filter, and 465-to 495-nm barrier filter.
Statistical Analysis
Statistical analysis was performed with the use of Instat software (GraphPad Software, San Diego, CA). All data were reported as mean AE standard deviation unless otherwise noted. Statistically significant differences were determined by 2-tailed Student t tests, and statistical significance was defined as P < .05.
Results

DPSC Characterization
DPSCs-HS were isolated and expanded in parallel with DPSCs-FBS. The morphology of DPSCs-HS appeared no different than DPSCs-FBS (Fig. 1A) . DPSC population doublings up to 27 and doublings times were calculated and found to be between 1 and 1.5 days for both DPSCs-HS and DPSCs-FBS, with no significant difference in PDT between cells expanded in the 2 growth conditions (Fig. 1B) .
expression of CD73, CD90, CD105, and CD45 was evaluated for DPSCs in that the presence or absence (CD45) of these markers are important determinants in defining ''stemness'' associated with mesenchymal stem cells (15) . Both expansion conditions resulted in yielding DPSCs, which expressed high levels of CD73 (>95%), CD90 (>98%), and CD105 (>85%) (Fig. 1C) . Additionally, between the conditions, there were no differences noted in the expression of these cell surface markers.
Angiogenic Factors Produced by DPSCs
It has been reported by our group and others that DPSCs have angiogenic capacity in vitro and in vivo. To determine what specific soluble factors play a role in this angiogenic capacity, a proteome profiler array was used to assess secreted molecules from both DPSCs-HS and DPSCs-FBS. Of the 55 angiogenesis-related proteins screened, the array showed that DPSCs produced varying levels of 54 of these analytes (Supplemental Figure S1 is available online at www.jendodon.com). In both DPSCs-HS and DPSCs-FBS, the angiogenic proteins endothelin, insulin-like growth factor binding protein-3 (interleukin 3), pentraxin 3, serpin E1, serpin F1, thrombospondin 1, tissue inhibitor of metalloproteinase-1, and vascular endothelial growth factor (VEGF) were most highly produced ( Fig. 2A) . In comparing angiogenic protein production between DPSCs-HS and DPSCs-FBS, quantitative analyses showed that DPSCs-HS secreted at least 1-fold higher concentrations of angiopoietin 1, angiopoietin 2, interleukin 8, persephin, and transforming growth factor beta than DPSCs-FBS ( Fig. 2A and B) . 
DPSC Production of Vascular Tissue within Tooth Slice
After transplantation of DPSCs-HS and DPSCs-FBS in tooth slice/ scaffolds, blood vessel analysis was performed to determine the in vivo vascular potential of these cells relative to their production of soluble angiogenic growth factors. Without transplantation of cells, we have previously reported that scaffolds have very low cellularity and minimal vascularity within the tooth/slice (data not shown). Transplantation of either DPSCs-HS or DPSCs-FBS in the present study consistently yielded a robust angiogenic response with the establishment of numerous blood vessels throughout the engineered tissue (Fig. 3A) . Quantitatively, this response was the same for both cell types (Fig. 3B) , confirming the vascular capacity of these cells to elicit an in vivo vascular response.
In addition to evaluating the overall vascular response, we determined if any of the transplanted cells differentiated into endothelial cells. Through factor VIII staining of human cells, we found that a significant number of vessels were composed of transplanted cells (Fig. 3A) . After quantification, it was observed that up to 50% of the vasculature was composed of transplanted cells, either DPSCs-HS or DPSCs-FBS (Fig. 3C) . These data indicate that not only are DPSCs-HS and DPSCs-FBS capable of promoting angiogenesis in vivo but that they are also capable of differentiating into endothelial cells.
Formation of Predentin
We consistently observed that the tissues generated in the pulp chambers of tooth slice/scaffolds seeded with DPSCs-HS and DPSCs-FBS were well organized, showing architectural and histologic characteristics that closely resemble those of normal human dental pulps (Fig. 4A) . In these specimens, the new tissue that was generated centripetally in the pulp chamber of tooth slice/scaffolds seeded with DPSCs contained dentinal tubules and a clearly defined adjacent predentin layer. Under ultrastructural analyses, we have previously shown that in this model cell transplantation of the appropriate cell types yields cells that present with eccentric polarized nuclei positioned at the basal part of the cell body, a well-developed Golgi complex, and a rough endoplasmic reticulum with multiple cytoplasmic vesicles (16) .
The ability of DPSCs-HS and DPSCs-FBS to differentiate into odontoblasts to produce dentin was further evaluated with confocal microscopy in tooth slices implanted into mice that were injected with tetracycline, which stains structures actively undergoing mineralization by incorporating into these tissues. Confocal microscopy showed well-defined fluorescent lines in the tooth slice/scaffolds containing DPSCs-HS and DPSCs-FBS (Fig. 4B) , coinciding with the timing of injections of tetracycline. Analysis of these data indicates that DPSCs-HS can differentiate into cells that secrete a mineralized dentin matrix at a rate similar to that of DPSCs-FBS and that observed in normal human dental pulp.
Discussion
Cell therapy offers promise for the regeneration of dental pulp and dental pulp-derived tooth tissues. We previously reported on a clinically feasible approach to store teeth, isolate DPSCs, and expand DPSCs without using animal serum; however, the in vivo regenerative capacity of these DPSCs was not determined in these studies (10) . In this study, we identified specific soluble angiogenic factors produced by adult DPSCs and compared them with those cultured without animal sera (DPSCs-HS). We then evaluated the angiogenic responses of DPSCs-HS in vivo in a model of dental pulp regeneration. Transplantation of DPSCs-HS in a tooth slice yielded a robust angiogenic response and further induced the formation of predentin. To our knowledge, this study is the first to show the in vivo regenerative capacity of adult DPSCs isolated and expanded in conditions completely devoid of animal serum or exogenous growth factors.
In evaluating the angiogenic potential of proteins produced by DPSCs, Bronckaers et al (17) recently reported that, over the course of 48 hours, DPSCs secrete high levels of angiogenic molecules. Additionally, the level of production of these factors was sufficient to stimulate endothelial cell migration and angiogenesis in vivo. Our findings were consistent with these data in that high levels of proteins were contained in the overnight conditioned medium of DPSCs cultured in both animal and human sera. In fact, as noted in the Results section, some of these factors were more highly expressed in the HS condition than in the FBS condition. It is well-known that specific conditions of the microenvironment, like hypoxia, can induce the up-regulation of stem cellmediated angiogenesis (18, 19) . It has more recently been shown that not only can hypoxia induce the expression of VEGF specifically from DPSCs (20) but also that fibroblast growth factor-2 can directly up-regulate VEGF and hepatocyte growth factor secretion from pulp cells of deciduous teeth (SHEDs) (21) . Through similar mechanisms to fibroblast growth factor-2, there could be components of the human sera that induce or up-regulate the production of specific angiogenic proteins from DPSCs. Additional studies are underway to identify what these components of human sera may be.
Our group and others have used various models to investigate the in vivo angiogenic capacity of pulp-derived stem cells from both primary (SHEDs) and adult (DPSCs) teeth, and it is clear that they maintain strong angiogenic potential after transplantation (4, (21) (22) (23) (24) . Through cotransplantation with endothelial cells or transplantation alone, these cells have been shown to induce angiogenesis attributed primarily to their release of trophic factors. Janebodin et al (23) observed that after transplantation DPSCs also served as pericytes, surrounding mature vessels. In the tooth slice model, we have shown previously with beta galactosidase (Lac Z) staining that SHEDs have the capacity to differentiate into endothelial cells and anastomose with the host vasculature to differentiate into endothelial cells (16) . Our previous findings with SHEDs are consistent with those in the present study in which transplanted adult DPSCs took on an endothelial cell phenotype and formed functional vessels containing red blood cells, which anastomosed with the host vasculature. Additionally, in this study, the capacity of DPSCs-HS to form a vasculature was no different than that of DPSCs-FBS. As such, our current finding that DPSCs maintain their in vivo angiogenic capacity when never being exposed to animal sera has broad-based cell therapy implications for dental pulp regeneration. Although this study and others have shown that DPSCs can enhance vascular tissue formation in vivo, being able to achieve regeneration of dental pulp tissue is the ultimate in vivo goal. To this end, there are only a few limited reports of in vivo pulp regeneration using DPSCs; yet, these reports use animal serum in their isolation and culture of DPSCs (20, 22, 25) . Here, we cite the first report of in vivo pulp regeneration using DPSCs isolated in conditions completely devoid of animal serum or exogenous growth factors. In preparation for clinical trials, Nakashima and Iohara (26) have recently reported the use of human serum for the isolation of human DPSCs mobilized using factors such as granulocyte colony stimulating factor and basic fibroblast growth factor (22, 27) . Although they report efficacy in pulp regeneration using these protocols, from the standpoint of feasibility and costeffectiveness, it would be most ideal if exogenous growth factors were not needed to obtain the desired regenerative outcomes. A completely serum-free approach would be ideal, and we have previously reported on the development of a serum-free system for periodontal ligament stem cells and SHEDs (28) . Although this media supported the growth and expansion of periodontal ligament stem cells and SHEDs, it did not support the proliferation and expansion of DPSCs. As a result, we evaluated human serum as an alternative to animal serum for these DPSCs, and our early results are encouraging using DPSCs-HS without the need for exogenous growth factors or animal serum. However, larger animal models are needed and being planned in immunocompetent hosts to rigorously evaluate the pulp regenerative potential of DPSCs-HS.
In conclusion, this study provides strong evidence that adult DPSCs can be isolated and expanded in media devoid of animal serum or exogenous growth factors and still maintain potent angiogenic properties. Additionally, after their transplantation, DPSCs-HS yield regeneration of dental pulp tissue evidenced by their differentiation into endothelial cells to participate in forming a functional vasculature and their formation of predentin tissue over time. Further preclinical studies are planned using clinically acceptable conditions (26) to optimize protocols in preparation for clinical trials evaluating DPSC-mediated pulp regeneration.
